TGFB1 and neoplasm: For instance, research has demonstrated that chemotherapy-induced IL-1β can trigger NET formation, which subsequently activates the TGF-β signaling pathway in tumor cells, promoting epithelial-mesenchymal transition and chemotherapy resistance in breast cancer lung metastasis (59).